Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients
Advanced Accelerator Applications
Advanced Accelerator Applications
Brahms AG
Ipsen
Novartis
Amgen
Novartis
Eli Lilly and Company
Novartis
Mateon Therapeutics
Novartis
Novartis
Novartis
Molecular Insight Pharmaceuticals, Inc.
Cylene Pharmaceuticals
CASI Pharmaceuticals, Inc.
Callisto Pharmaceuticals